Evidence-based cannabis information for adults 50 and older Peer-reviewed citations · Always talk to your doctor or pharmacist · No product sales

Cannabis in Assisted Living and Long-Term Care

15+ states have some protections for medical cannabis patients in licensed facilities. The Illinois model, federal Fair Housing limits, and what to ask before you move in.

The Federal-State Collision

Long-term care cannabis policy is a patchwork driven by a fundamental tension: expanding state medical cannabis protections collide with ongoing federal prohibition. Approximately 15 to 20 states have addressed medical cannabis in long-term care settings to varying degrees, but no uniform national standard exists.

The core legal problem is straightforward. The Social Security Act requires skilled nursing facilities to "operate and provide services in compliance with all applicable Federal, State, and local laws." Allowing cannabis technically violates federal law, placing facilities that accept Medicare or Medicaid funding at theoretical risk of exclusion from federal programs.

The practical reality: no nursing home has been cited by CMS for allowing medical cannabis under state law. The theoretical risk is real. The actual enforcement, so far, is zero. Moderate evidence

State Laws That Protect Residents

California — Ryan's Law (SB 311)

Effective January 2022, Ryan's Law is the most comprehensive state protection for cannabis use in healthcare facilities. It requires hospitals, skilled nursing facilities, and hospice facilities to permit terminally ill patients (prognosis of one year or less) to use medicinal cannabis. Key provisions:

  • Patients or their designees may bring cannabis into the facility
  • Facilities must develop written guidelines for cannabis use
  • Facilities may not prohibit use solely because cannabis is federally Schedule I
  • Facilities may suspend policies if CMS or the Department of Justice takes formal enforcement action

Minnesota

Effective March 2025, Minnesota's statute prohibits health care facilities from banning medical cannabis use by enrolled patients, while permitting "reasonable restrictions" on how and where cannabis is consumed.

New Jersey

Has codified an "institutional caregiver" concept allowing nursing homes and hospice centers to designate staff members to assist with cannabis administration.

Massachusetts

DPH regulations allow nursing home employees to serve as personal caregivers who can purchase, prepare, and administer cannabis to registered patients — one of the few states addressing the staff administration question directly.

The Hebrew Home Model

The Hebrew Home at Riverdale in New York — a 735-bed facility — has been nationally recognized for developing an innovative medical marijuana program for its residents. It serves as a model for how large facilities can accommodate cannabis within existing regulatory frameworks.

But most facilities remain reluctant. Fear of losing Medicare and Medicaid certification — which requires compliance with federal law — outweighs the absence of actual enforcement. Administrators who might personally support patient access hesitate to assume legal risk on behalf of their institutions.

Assisted Living vs. Skilled Nursing

The distinction matters enormously. Assisted living facilities are state-regulated, not federally regulated. They do not depend on Medicare certification the way skilled nursing facilities do. This means the federal compliance barrier is significantly lower, and assisted living communities have generally been more willing to accommodate cannabis use by residents.

If you are choosing between facility types and cannabis access is important to you, this regulatory difference should factor into your decision.

HUD guidance adds a separate complication: housing communities may deny admission to new residents who use medical marijuana. Reasonable accommodation requests under the Fair Housing Act are not required for federally illegal substances. Ask about cannabis policies before signing any residential agreement.

The Staff Administration Question

Whether staff members can administer medical cannabis remains the thorniest question. In most states, facility nursing staff cannot administer a Schedule I substance without risking their professional licenses. Virginia's SB 185 would allow nursing home and hospice employees to administer CBD/THC-A oil — an approach that may serve as a template for other states.

The most common model remains self-administration: patients or designated caregivers manage cannabis use, while facilities create policies around it — no smoking, secure storage, specific consumption locations.

Memory Care: Unique Challenges, Strong Rationale

Memory care units face the most difficult version of every long-term care cannabis question:

  • Patients with moderate-to-severe dementia typically cannot provide informed consent, requiring surrogate authorization
  • Cannabis must be secured from cognitively impaired residents who might access it inadvertently
  • Administration requires caregiver assistance, raising staff-licensing issues

Yet the clinical rationale for cannabinoid use in memory care may be the strongest of any long-term care setting. The THC-AD Trial (Rosenberg, Forester et al., 2025, American Journal of Geriatric Psychiatry) — an 8-year, multi-site, double-blind, placebo-controlled RCT of 75 participants aged 60 to 95 — found that dronabinol 5 mg twice daily reduced agitation by approximately 30%, with a moderate effect size of 0.53 and no increased intoxication, delirium, or falls. Strong evidence

This compared favorably to antipsychotics, which carry black-box warnings for increased mortality in dementia patients. Michigan, Oregon, and Rhode Island specifically include "agitation of Alzheimer's" as a qualifying condition for medical cannabis.

For more on the evidence for cannabis in dementia, see Alzheimer's & Dementia.

Related Pages